Larson Financial Group LLC Grows Position in Select Medical Holdings Co. (NYSE:SEM)

Larson Financial Group LLC raised its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 11.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 89,611 shares of the health services provider’s stock after acquiring an additional 9,541 shares during the period. Larson Financial Group LLC owned approximately 0.07% of Select Medical worth $3,125,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of SEM. Kingsview Wealth Management LLC bought a new position in Select Medical during the third quarter valued at $1,927,000. Cerity Partners LLC raised its position in shares of Select Medical by 4.8% during the 3rd quarter. Cerity Partners LLC now owns 62,434 shares of the health services provider’s stock valued at $2,177,000 after buying an additional 2,835 shares in the last quarter. Citigroup Inc. lifted its holdings in shares of Select Medical by 85.3% in the 3rd quarter. Citigroup Inc. now owns 140,703 shares of the health services provider’s stock valued at $4,906,000 after acquiring an additional 64,751 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Select Medical by 1.5% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after acquiring an additional 24,439 shares in the last quarter. Finally, Foundry Partners LLC increased its stake in Select Medical by 3.6% during the third quarter. Foundry Partners LLC now owns 245,860 shares of the health services provider’s stock worth $8,573,000 after acquiring an additional 8,561 shares during the last quarter. 89.48% of the stock is currently owned by institutional investors.

Select Medical Stock Performance

Shares of Select Medical stock opened at $39.67 on Friday. Select Medical Holdings Co. has a 52 week low of $22.26 and a 52 week high of $40.98. The company has a market capitalization of $5.14 billion, a PE ratio of 18.54, a price-to-earnings-growth ratio of 1.75 and a beta of 1.42. The stock’s fifty day moving average is $35.19 and its two-hundred day moving average is $35.02. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm’s revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.46 EPS. As a group, analysts expect that Select Medical Holdings Co. will post 2.16 earnings per share for the current year.

Select Medical Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th will be issued a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.26%. Select Medical’s payout ratio is 23.36%.

Wall Street Analyst Weigh In

SEM has been the subject of several analyst reports. StockNews.com lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Thursday. Benchmark restated a “buy” rating and issued a $48.00 price target on shares of Select Medical in a research report on Friday, November 1st. Bank of America initiated coverage on shares of Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective on the stock. Finally, Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday, November 4th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $40.75.

Select Medical Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.